Viking Global Investors LP Royalty Pharma PLC Transaction History
Viking Global Investors LP
- $31.6 Billion
- Q2 2025
A detailed history of Viking Global Investors LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Viking Global Investors LP holds 2,597,460 shares of RPRX stock, worth $93.1 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
2,597,460
Previous 10,563,939
75.41%
Holding current value
$93.1 Million
Previous $329 Million
71.54%
% of portfolio
0.3%
Previous 1.1%
Shares
21 transactions
Others Institutions Holding RPRX
# of Institutions
504Shares Held
301MCall Options Held
1.96MPut Options Held
327K-
Morgan Stanley New York, NY46.6MShares$1.67 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$825 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$785 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$646 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...